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Background: African swine fever (ASF) is a contagious viral disease which can cause up to 100% mortality among
domestic pigs leading to serious socio-economic impact on people’s livelihoods. ASF is endemic in Uganda and
there is paucity of information on the epidemiology of the disease. The major aim of this study was to determine
the seroprevalence and prevalence of African swine fever virus (ASFV) in apparently healthy slaughter pigs at
Wambizi slaughterhouse in Kampala city, Uganda. We also estimated the presence of ASFV antibodies and circulating
viral antigens in pigs from selected districts of Uganda during targeted surveillance. We analysed 540 and 181 blood
samples collected from slaughter pigs and pigs from targeted surveillance districts respectively.
Results: The prevalence of ASFV in slaughter pigs was 52.96% (95% CI, 48.75-57.14) and 11.5% (95% CI, 9.06-14.45) by
ELISA and PCR respectively. In surveillance districts, the proportion of ASFV positive pigs was 53.59% (95% CI,
46.33-60.71) and 0.55% (95% CI, 0.1-3.06) by ELISA and PCR respectively.
Conclusion: The study has found out a high seroprevalence of ASFV antibodies in apparently healthy slaughter pigs
and also a high proportion of ASFV antibody seropositive pigs in surveyed districts in Uganda indicating exposure to
ASFV. However, there was a lower prevalence of ASFV infection implying that there could be low virulent strains of
ASFV circulating in domestic pigs in Uganda which requires further investigation.
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African swine fever (ASF) is a viral disease with a devas-
tating impact on the pig industry in sub-Saharan Africa
[1]. The disease is caused by double-stranded DNA virus
with an icosahedral symmetry that belongs to genus
Asfivirus and family Asfarviridae [2]. ASF virus repli-
cates primarily in cells of the reticulo-endothelial system
[3], and consequently blood, lymph node, spleen, liver
and tonsil are the preferred specimens for laboratory
examination [4]. The epidemiology of ASF is complex,
transmission is direct and vector-borne, and the disease
has well recognized sylvatic and domestic cycles [5].
ASF is highly contagious and is transmitted by direct
contact between infected pigs and susceptible ones or by
contact with infectious secretions/excretions [4]. The
virus is highly resistant in tissues and the environment,* Correspondence: fmwiine@gmail.com
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reproduction in any medium, provided the orcontributing to its transmission over long distances
through swill feeding and fomites (e.g., contaminated
material, vehicles or visitors to pig premises) [4].
Uganda has the largest pig population in Eastern Af-
rica standing at 3.2 million [6]. Pig farming is one of the
fastest growing livestock activities in the rural areas of
Uganda and has become very attractive throughout the
country as a means of increasing food, income and em-
ployment [7,8]. But ASF is an economically important
and frequently lethal disease of domestic pigs which has
hampered the development of the pig industry in
Uganda [8] and other affected countries [1].
In endemic areas, diagnosis may be based on detection
of antibody but in new introductions of disease it is pref-
erable to detect the virus. Procedures, which have been
used for ASF virus antigen detection, include the trad-
itional haemadsorption test (HAD; [9], radioimmunoassay
(RIA; [10];, direct immunofluorescence [11] and polymer-
ase chain reaction (PCR; [12-14] and recently LAMP [15].
Immunocytochemistry and in situ hybridization have beenl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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techniques are not ideally suited to routine diagnosis [17].
Serological examinations may be the best way to detect
pigs infected with ASF virus [18]. Recently, an ELISA was
developed for the serodiagnosis of ASFV in Africa inde-
pendent of the geographical origin of the sera based on
the p30 recombinant protein (p30r) obtained from an East
African viral isolate (Morara Strain) [19]. However, the
p30r was not subjected to samples from Uganda and
Kenya where genotype IX is known to circulate [19].
Following ASF outbreaks, antibodies can persist in re-
covered pigs for long periods after infection, sometimes
for life [20]. Previous experimental studies on persist-
ence of ASFV revealed that viral DNA is detectable in
peripheral blood mononuclear leukocytes at greater than
500 days post infection by PCR assay, although it was
not possible to isolate the infectious virus from that
sample [21]. This indicates that monocytes/macrophages
may be persistently infected with ASFV [22]. Although
no long-term carrier state has been demonstrated, these
pigs were shown to remain infected for up to several
weeks [23], and can transmit the disease to other sus-
ceptible pigs. Sub-clinically infected, chronically infected
or recovered pigs are likely to play an important role in
the epidemiology of the disease, for disease persistence
in endemic areas as well as for causing sporadic out-
breaks or introduction into disease-free zones [4,24-26].
In endemic areas, mortality rates have decreased and
sub-clinical or chronic ASFV infections have become
more frequent [24,27,28]. Pigs infected with isolates of
low virulence may seroconvert without symptoms, abort
or develop chronic African swine fever [20,29].
The major aim of this study was to determine the
seroprevalence and prevalence of ASFV in apparently
healthy pigs slaughtered in Wambizi slaughter house in
Kampala city. The study also aimed at estimating the
presence of ASFV antibodies in pigs from selected dis-
tricts with no active ASF outbreak in order to give an
insight in presence of the antibodies and circulation of
the viral antigens in apparently health domestic pigs.
Methods
Study sites
The study was carried out in Wambizi slaughterhouse, the
largest pig slaughterhouse in Kampala City, run by a
farmer cooperative located in Nalukolongo. This slaughter
house was chosen because it is the largest in Kampala and
receives pigs from most regions in the country. In addition,
targeted surveillance was done in 10 selected districts of
Uganda. These districts were conveniently selected for
purposes of this study. The districts included Masaka,
Mityana, Mubende, Kyenjojo, Kamwengye, Kasese,
Bundibugyo, Kibaale, Hoima and Masindi (Figure 1).
Sample villages and pig herds were identified with theadvice of the respective District and sub county Veterin-
ary officers, and farmers’ consent was obtained before
pig sampling.
Study design
A cross-sectional study to estimate ASFV prevalence in
slaughter pigs was conducted for a period of one year.
For stratified random sampling at the slaughterhouse,
we used the formula k = N/n [30], where k is the kth
element, n is the sample size, and N is the population
size. We were collecting 20–25 blood samples (n) per
visit to the slaughterhouse. Since it was estimated that
an average of 100 pigs (N) were slaughtered per day it
therefore meant that the k value was approximately 5.
We therefore sampled every fifth slaughtered pig and re-
corded the origin (region and district). The information
on the origins was provided by the traders at the slaugh-
ter house though some pigs sampled were from an un-
known origin. During every visit to the abattoir each pig to
be slaughtered had an equal chance/probability of being se-
lected. Only apparently healthy pigs were sampled. A con-
venient sampling strategy was used during surveillance to
select pig herds from which blood samples were collected.
Sample size determination
To estimate the prevalence of ASFV in apparently
healthy slaughter pigs at Wambizi slaughter house, the
sample size for pigs that achieved 5% level of precision
at 95% confidence level was calculated using the formula
described by [31]. n = Z2 X P (1-P)/d2; Where; n = Sample
size, Z = 1.96 at 95% confidence level, P = Probable preva-
lence of ASFV in pigs slaughtered at Wambizi (taken as
6%), d = Standard error (taken as 2%). However, 540 blood
samples were successfully analysed in this study. In
addition, we collected 181 blood samples from the 10 dis-
tricts where targeted surveillance was conducted.
Sample collection
Two visits to the slaughter house were made per month
and blood samples collected. Blood was collected from
the jugular vein into vacutainers for serum and EDTA
tubes. Serum was then separated in the laboratory and
stored at -20ºC till used in the ELISA assay. An aliquot
of the blood sample was stored at -20 ºC till used for
DNA extraction for PCR.
ELISA assay
An indirect ELISA was performed to determine the
presence of ASF virus antibodies in pig sera collected
from Wambizi slaughterhouse and selected districts in
Uganda. The procedure was as described previously
[32,33]. We used a VP73 antigen (a purified protein ex-
tract from ASFV received as a donation from the OIE
reference laboratory, Ingenasa, Spain), and a secondary
Figure 1 Map of Uganda showing origins of slaughter pigs and districts of targeted African swine fever surveillance.
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raddish peroxidase) diluted 1:5000 in dilution buffer.
Optical Densities (ODs) were measured at 490 nm. The
cut offs were determined as previously described [32,33].
The cut-off was then used to determine whether a sam-
ple was positive, negative or inconclusive [32,33].
DNA extraction
Viral DNA was extracted directly from 200 μl aliquots of
blood collected in EDTA tubes using the DNeasy Blood
and tissue kit (QIAGEN®, USA).
Genomic amplification
A 278 bp region corresponding to the central portion of
the p72 gene was amplified using the diagnostic primers,
primer 1 (5′-ATGGATACCGAGGGAATAGC-3′) andprimer 2 (5′-CTTACCGATGAAAATGATAC-3′) to
confirm the presence of ASFV DNA [34].
Genomic amplification was performed in a 50 μl vol-
ume in the presence of 200 μmol/L dNTP, 0.25 μmol/L
of each primer, 2.5U of thermostable Taq DNA polymer-
ase and 3 μl of DNA extract. The template was amplified
following 40 cycles of denaturation at 96 ºC for 12 s, an-
nealing at 53ºC for 20 s and extension at 70ºC for 30s.
Amplification products were loaded on a 1.5% agarose
gel and run against a 100 bp DNA ladder. Once suffi-
cient electrophoretic separation was obtained, the
products were visualized by UV irradiation and
stained with ethidium bromide. The gels were photo-
graphed in order to provide a soft copy result for the
diagnostic products and a representative gel is shown
in Figure 2.
Figure 2 PCR amplification of the p72 gene. A 1.5% Agarose gel showing the representative results obtained with the diagnostic primers
targeting the central portion of the p72 gene of African swine fever virus. Lane M; λ DNA-Hind III and ϕx174 DNA-Hae III mix (Finnzymes)
Molecular weight DNA marker, Lanes 1,3,4,5,7,8,12,13,14 and15 are selected positive samples with approximately 278 bp band size. Lanes 2,6,9,10
and 11 are negative samples. Lane N is negative control and Lane P is a positive control.
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Proportion of ASFV seropositive slaughter pigs by
Indirect ELISA
The proportion of ASFV seropositive slaughter pigs and
their origins is summarized in Table 1. Most of the pigs
slaughtered (42.6%) at the slaughterhouse originated
from Masaka district. With the exception of Busoga,
Lango and Unknown, all the other districts from where
the slaughter pigs originated fall in central Uganda. This
implies that 81.9% of all the slaughtered pigs originated
from central Uganda. The overall proportion of slaugh-
ter pigs that were seropositive for ASFV over a one year
period was 52.96% (95% CI, 48.75-57.14).
Proportion of pigs with ASFV antibodies during field
surveillance by indirect ELISA
The proportion of pigs positive for ASFV antibodies dur-
ing field surveillance is summarized in Table 2. The
overall proportion of ASFV seropositive pigs during sur-
veillance was 53.59% (95% CI, 46.33-60.71).
Prevalence of ASFV by diagnostic PCR
A total of 62 blood samples out of 540 analyzed tested
positive for ASFV using the OIE recommended diagnos-
tic PCR (Table 3). ASFV prevalence was 11.5% (95% CI,
9.06-14.45) among the slaughter pigs sampled over a
one year period (February 2012 to January 2013). Out of
the 62 PCR positive samples 43 were positive for ASFV
antibodies, 12 were negative while 7 were inconclusive
by ELISA. Only one sample [0.55% (95% CI, 0.1-3.06)]
was positive by PCR out of the 181 pigs sampled during
field surveillance.
Monthly ASFV detection in slaughter pigs
ASF was detected most (42.2%) in the month of March
followed by November (20%) and, April (15.6%), May
(13.3%), June, December and January (11.1%), August
(6.5%), September (4.4%) and July (2.2%). There was no
ASFV detected in slaughter pigs in the months ofFebruary and October. The distribution of the sample
size from the different areas from which at least one
sample tested positive by PCR is shown in Table 4.
Discussion
The aims of the current study were to determine the
prevalence of ASFV in slaughter pigs in Wambizi
slaughterhouse, Kampala city and to determine the pro-
portion of ASFV seropositive domestic pigs during sur-
veillance in areas with no active ASF outbreak in order
to give an insight in presence of the antibodies and cir-
culation of the viral antigens in apparently health do-
mestic pigs in Uganda. The disease is endemic in the
country [35] and outbreaks have been reported since
2001 [8]. The inability of ASFV to induce neutralizing
antibodies has hampered the prevention and control of
the disease by vaccination and to date there is no vac-
cine for ASF. In the absence of effective vaccines, con-
trol is based on rapid laboratory diagnosis and the
enforcement of strict sanitary measures [36]. In ideal sit-
uations diagnosis of ASF should be carried out through
a combination of tests including the detection of viral
genome by PCR, the detection of viral antigen by anti-
gen ELISA or FAT and the detection of virus through
virus isolation. This is not however possible in many
countries like Uganda in which ASF is endemic, partly
due to high cost of molecular diagnostic tools and the dif-
ficulty and cost of carrying out virus isolation. Cheaper as-
says are available for the detection of ASF antigen, such as
the antigen ELISA and FAT; however, these assays have a
reduced sensitivity compared to PCR. In this study the
OIE recommended diagnostic PCR and ELISA were used
to determine the prevalence of ASFV. The early appear-
ance and long-term persistence of antibodies and the
lower cost compared to PCR-based methods emphasize
the relevance of antibody detection techniques in the con-
trol of the disease in affected countries [37].
The majority (81.9%) of the pigs slaughtered at
Wambizi slaughterhouse originated from the central
Table 1 Proportion of ASFV seropositive slaughter pigs at Wambizi slaughterhouse (February 2012- January 2013)
Origin of pigs Total sampled Number positive Number inconclusive Number negative Proportion of seropositive pigs
Busoga 54 35 4 15 64.7
Gomba 8 3 2 3 33.33
Kalungu 47 15 3 29 32
Kampala 38 5 2 31 11.76
Kiboga 18 8 1 9 42.86
Lango 23 11 1 11 47.37
Lukaya 19 8 1 10 42.86
Masaka 230 130 21 79 56.5
Mityana 27 27 0 0 100
Mpigi 17 2 1 14 9.09
Nakaseke 5 5 0 0 100
Nakasongola 9 9 0 0 100
Sembabule 10 5 0 5 50
Unknown 21 17 1 3 80.95
Wakiso 14 6 2 6 42.86
Total 540 286 39 215 52.96
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ried out in the same slaughterhouse where 68% of the
slaughtered pigs originated from the central region [38].
This could be because Wambizi slaughterhouse is lo-
cated in the central region or even because this region
has the highest number of pigs in Uganda [6].
In this study the overall seroprevalence of ASFV in
slaughter pigs over a one year period was found to be
52.96% (95% CI, 48.75-57.14). This is a higher seropreva-
lence compared to previous studies in Uganda [39-42]
and other countries [43,44]. A similar study on slaughter
pigs in Mubende district in central Uganda found a
much lower prevalence of 0.2% [39]. Another study car-
ried out in Rakai district in Southern Uganda reported a
seroprevalence of 2.1% [40]. However, a previous study
on 39 porcine serum samples obtained from centralTable 2 Proportion of ASFV seropositive pigs during surveilla
District sampled Total sampled Number positive Number inco
Bundibujo 12 11 1
Hoima 6 4 1
Kamwenge 9 7 2
Kasese 8 8 0
Kibaale 16 11 1
Kyenjojo 2 1 1
Masaka 95 33 25
Masindi 13 8 2
Mityana 7 6 1
Mubende 13 8 3
Total 181 97 37Ugandan districts revealed that none of them were anti-
body positive for ASF using the OIE recommended
ELISA [42]. In a study carried out in Gulu district in
Northern Uganda on 6 pigs one year post ASF outbreak
survival only 3 pigs were found to have antibodies
against ASFV [41] suggesting persistence of antibodies
and/or circulation of a low virulent ASFV. The results
obtained in this study are strikingly different from previ-
ous similar studies in Uganda. This could be attributed
to the fact that pigs from which blood samples were col-
lected in this study were from diverse geographical ori-
gins (Figure 1) in comparison to previous studies in
Uganda that sampled only in one district [39-41]. Con-
trary, the current study was carried out for a period of
12 months in slaughter domestic pigs while other previ-
ous studies in Uganda were of a shorter period of timence in selected districts of Western and Central Uganda












Table 3 Proportion of PCR positive pigs and their areas









Busoga 54 11 20.4
Kalungu 47 7 14.9
Kampala 38 4 10.5
Lango 23 7 30.4
Masaka 230 27 11.7
Nakaseke 5 1 20
Nakasongola 9 2 22.2
Sembabule 10 2 20
Unknown 21 1 4.8
Total 540 62 11.5
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used a very low sample size compared to this study.
Nevertheless, a study by Muwonge and others (2012)
used a higher sample size but the pigs were from one
geographical locality of Mubende district in Central
Uganda [39].
In addition, the proportion of ASFV antibody positive
domestic pigs during field surveillance was 53.59% (95%
CI, 46.33-60.71). This is close to the observed seropreva-
lence (52.96%) of slaughter pigs in this study. Since out-
breaks occur sporadically in most parts of Uganda [8], it
could also be that following an acute phase of ASF, the
pigs that survive have detectable levels of antibodies in
serum against the ASFV after 7–12 days post develop-
ment of the first clinical symptoms [20]. These anti-
bodies persist for long time, probably for life [20]. The
higher seroprevalence obtained in this study shows that
approximately half of the pigs slaughtered have been ex-
posed to ASFV.Table 4 Number of ASF PCR positive domestic pigs
slaughtered in Wambizi slaughterhouse by Month and
origin
Origin of pigs Months (Feb 2012-Jan 2013)
F M A M J J A S O N D J
Busoga _ _ 2 4 _ _ _ _ _ 3 _ 2 (11)
Kalungu _ _ _ _ 4 _ _ _ _ 2 _ 1 (7)
Kampala _ _ _ _ _ 1 2 _ _ _ 1 _ (4)
Lango _ 2 4 _ _ _ _ _ _ _ 1 _ (7)
Masaka _ 17 _ 2 _ _ 1 _ _ 4 2 1 (27)
Nakaseke _ _ _ _ _ _ _ 1 _ _ _ _ (1)
Nakasongola _ - 1 - _ _ _ _ _ _ _ 1 (2)
Sembabule _ _ _ _ 1 _ _ _ _ _ 1 _ (2)
Unknown _ _ _ _ _ _ _ 1 _ _ _ _ (1)
Total 0 19 7 6 5 1 3 2 0 9 5 5 (62)The overall ASFV prevalence determined by PCR
among the slaughtered pigs sampled over a one year
period was found to be 11.5% (95% CI, 9.06-14.45). The
proportion of apparently healthy pigs that were ASFV
antigen positive during field surveillance was 0.55%. This
could be that this pig had an active infection or was a
survivor of an acute infection. The low proportion of
ASFV antigen positive pigs could also be attributed to
the effect of temperature differences from field collec-
tion sites during transportation to the laboratory which
could probably have degraded the viral DNA. The use of
FTA cards would have mitigated this problem. A related
study in Rakai district in Southern Uganda found a
prevalence of 3.3% in apparently healthy domestic pigs
[40]. In this study ASFV was detected in slaughter pigs
in all the months except in February and October with
the majority detected in the month of March. A previous
study on the epidemiology of ASF outbreaks in Uganda
has reported ASF in all months between 2001 and 2012
with the majority of the outbreaks occurring in the dry
season [8]. Uganda experiences two dry seasons of De-
cember to February and June to August [45]. The find-
ings in this study agree with the previous study that
showed a sporadic pattern of ASF occurrence, the differ-
ence being the increase of ASF outbreaks at the peaks of
the dry seasons that was not observed in the current
study.
Out of the 62 PCR positive samples 43 were positive
for ASFV antibodies. These pigs could have been chronic
carriers, subclinically infected and/or recently infected
with the virus but not showing the clinical signs. The
presence of ASFV antibodies and ASFV DNA in appar-
ently healthy domestic pigs suggests that circulation of
ASF virus in the pig population in Uganda is a critical
issue and that these pigs may play a great role in the
maintenance of ASF in the country and may be spread
by in-apparent carriers to other virus free swine. The de-
tection of ASF specific antibodies is indicative of previ-
ous infection [37], and since antibodies are produced
from the first week of infection and persist for long pe-
riods they are appropriate markers for the diagnosis of
the disease [33].
Future studies should aim at determination of IgM ti-
tres which would be useful for epidemiological studies in
endemic areas since positive detection of antibodies
would indicate previous exposure and not necessarily a
current infection. In such cases, the IgM/IgG ratio
would distinguish between exposed and recently infected
pigs [46]. Other recently developed ASFV recombinant
proteins for serodiagnosis of ASF need to be validated
for use in endemic countries like Uganda.
In this study we had limitations that could have intro-
duced bias. The convenient sampling approach used
during surveillance was a drawback in that the samples
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tions in the selected districts and this could not be used
to estimate the ASFV prevalence. Furthermore, we expe-
rienced logistical constraints; the reason why sample col-
lection at the slaughter house was for only two days in a
month. The study could have probably benefited more if
samples were collected daily for the entire year.
Conclusion
In conclusion, the study has found out a high seropreva-
lence of ASFV in apparently healthy slaughter pigs and
also a high proportion of ASFV seropositive pigs in sur-
veyed districts in Uganda. The fact that most seroposi-
tive pigs were PCR negative indicates that they were
exposed to ASFV but had recovered from the infection,
which is suggestive of circulation of low virulent strains
which requires further investigation.
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